Testing effectiveness (Phase 2)Active Not RecruitingNCT06868290
What this trial is testing
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Who this might be right for
ANCA Associated Vasculitis (AAV)
Novartis Pharmaceuticals 126